In this Issue

Diabetics are most adherent around meal times, especially during breakfast and toward the beginning of the week, according to a review of Medisafe’s more than 160,000 diabetes patients who utilize its adherence tool in an effort to better manage the condition.

(To view the full Diabetes Report, click here.)

Shea Moisture is unleashing the second phase of its call-to-action program, #BreakTheWalls.

This time, the Sundial Brands-owned skin and hair line is challenging the concept of a one-size-fits all representation of beauty.

Sam’s Club last month hosted a health screening day specifically catering to the health needs of the women shopping the store with a “Support Her Health” screening offering. “Women often prioritize their families’ needs and work responsibilities over their own health and wellness, but it’s important to ensure regular health checkups don’t fall off the to-do list,” said Tara Raddohl, senior director of corporate communications at Sam’s Club.

Sales of OTC medicines continued on a strong growth trajectory of more than 3%, growing by approximately $1.4 billion in dollar volume to $45.6 billion for the 52 weeks ended Oct. 2, according to IRI data. And that’s primarily organic growth from existing brands; there were no big Rx-to-OTC switches driving the kind of gangbuster growth as there were in each of the two years prior.

(To view the full OTC Trend Report, click here.)

A pair of personal lubricant suppliers in the last few months have launched new products specifically designed to appeal to women.

(To view the full OTC Women's Health Report, click here.)

In 2017, how people shop, why people shop and what they’re shopping for will all be shaped by two overarching themes — access to digitized health information and wearables, as well as other Bluetooth-enabled, diagnostic-style self-care offerings.

(To view the full OTC Trend Report, click here.)

In the nearly five years since the Generic Drug User Fee Agreement was enacted under the Food and Drug Administration Safety and Innovation Act of 2012, through the FDA’s Office of Generic Drug, GDUFA has generated some $1.5 billion in user fees and has seen 1,992 approvals issued.

(To view the full Category Review, click here.)

Today’s diabetes patients represent a coveted consumer base for retail pharmacy no matter how you characterize that diabetes spend. For example, consumers with diabetes spend 35% more on OTC products than the average consumer, noted Jeff Gregori, group VP consumer and shopper analytics for Nielsen, during a presentation at the 2016 National Association of Chain Drug Stores Total Store Expo.